Cargando…
cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
“clinical NEUroPROteomics of neurodegenerative diseases” (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. T...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945639/ https://www.ncbi.nlm.nih.gov/pubmed/20886057 http://dx.doi.org/10.4061/2010/548145 |
_version_ | 1782187230749523968 |
---|---|
author | Spitzer, Philipp Klafki, Hans Wolfgang Blennow, Kaj Buée, Luc Esselmann, Hermann Herruka, Sanna-Kaisa Jimenez, Connie Klivenyi, Peter Lewczuk, Piotr Maler, Juan Manuel Markus, Katrin Meyer, Helmut E. Morris, Chris Müller, Thorsten Otto, Markus Parnetti, Lucilla Soininen, Hilkka Schraen, Susanna Teunissen, Charlotte Vecsei, Laszlo Zetterberg, Henrik Wiltfang, Jens |
author_facet | Spitzer, Philipp Klafki, Hans Wolfgang Blennow, Kaj Buée, Luc Esselmann, Hermann Herruka, Sanna-Kaisa Jimenez, Connie Klivenyi, Peter Lewczuk, Piotr Maler, Juan Manuel Markus, Katrin Meyer, Helmut E. Morris, Chris Müller, Thorsten Otto, Markus Parnetti, Lucilla Soininen, Hilkka Schraen, Susanna Teunissen, Charlotte Vecsei, Laszlo Zetterberg, Henrik Wiltfang, Jens |
author_sort | Spitzer, Philipp |
collection | PubMed |
description | “clinical NEUroPROteomics of neurodegenerative diseases” (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. The ultimate goal of cNEUPRO is to identify one or more valid biomarker(s) in blood and CSF applicable to support the early and differential diagnosis of dementia disorders. The consortium covers all steps required for the discovery of novel biomarker candidates such as acquisition of high quality CSF and blood samples from relevant patient groups and controls, analysis of body fluids by various methods, and finally assay development and assay validation. Here we report the standardized procedures for diagnosis and preanalytical sample-handling within the project, as well as the status of the ongoing research activities and some first results. |
format | Text |
id | pubmed-2945639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | SAGE-Hindawi Access to Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-29456392010-09-30 cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases Spitzer, Philipp Klafki, Hans Wolfgang Blennow, Kaj Buée, Luc Esselmann, Hermann Herruka, Sanna-Kaisa Jimenez, Connie Klivenyi, Peter Lewczuk, Piotr Maler, Juan Manuel Markus, Katrin Meyer, Helmut E. Morris, Chris Müller, Thorsten Otto, Markus Parnetti, Lucilla Soininen, Hilkka Schraen, Susanna Teunissen, Charlotte Vecsei, Laszlo Zetterberg, Henrik Wiltfang, Jens Int J Alzheimers Dis Review Article “clinical NEUroPROteomics of neurodegenerative diseases” (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. The ultimate goal of cNEUPRO is to identify one or more valid biomarker(s) in blood and CSF applicable to support the early and differential diagnosis of dementia disorders. The consortium covers all steps required for the discovery of novel biomarker candidates such as acquisition of high quality CSF and blood samples from relevant patient groups and controls, analysis of body fluids by various methods, and finally assay development and assay validation. Here we report the standardized procedures for diagnosis and preanalytical sample-handling within the project, as well as the status of the ongoing research activities and some first results. SAGE-Hindawi Access to Research 2010-09-19 /pmc/articles/PMC2945639/ /pubmed/20886057 http://dx.doi.org/10.4061/2010/548145 Text en Copyright © 2010 Philipp Spitzer et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Spitzer, Philipp Klafki, Hans Wolfgang Blennow, Kaj Buée, Luc Esselmann, Hermann Herruka, Sanna-Kaisa Jimenez, Connie Klivenyi, Peter Lewczuk, Piotr Maler, Juan Manuel Markus, Katrin Meyer, Helmut E. Morris, Chris Müller, Thorsten Otto, Markus Parnetti, Lucilla Soininen, Hilkka Schraen, Susanna Teunissen, Charlotte Vecsei, Laszlo Zetterberg, Henrik Wiltfang, Jens cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases |
title | cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases |
title_full | cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases |
title_fullStr | cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases |
title_full_unstemmed | cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases |
title_short | cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases |
title_sort | cneupro: novel biomarkers for neurodegenerative diseases |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945639/ https://www.ncbi.nlm.nih.gov/pubmed/20886057 http://dx.doi.org/10.4061/2010/548145 |
work_keys_str_mv | AT spitzerphilipp cneupronovelbiomarkersforneurodegenerativediseases AT klafkihanswolfgang cneupronovelbiomarkersforneurodegenerativediseases AT blennowkaj cneupronovelbiomarkersforneurodegenerativediseases AT bueeluc cneupronovelbiomarkersforneurodegenerativediseases AT esselmannhermann cneupronovelbiomarkersforneurodegenerativediseases AT herrukasannakaisa cneupronovelbiomarkersforneurodegenerativediseases AT jimenezconnie cneupronovelbiomarkersforneurodegenerativediseases AT klivenyipeter cneupronovelbiomarkersforneurodegenerativediseases AT lewczukpiotr cneupronovelbiomarkersforneurodegenerativediseases AT malerjuanmanuel cneupronovelbiomarkersforneurodegenerativediseases AT markuskatrin cneupronovelbiomarkersforneurodegenerativediseases AT meyerhelmute cneupronovelbiomarkersforneurodegenerativediseases AT morrischris cneupronovelbiomarkersforneurodegenerativediseases AT mullerthorsten cneupronovelbiomarkersforneurodegenerativediseases AT ottomarkus cneupronovelbiomarkersforneurodegenerativediseases AT parnettilucilla cneupronovelbiomarkersforneurodegenerativediseases AT soininenhilkka cneupronovelbiomarkersforneurodegenerativediseases AT schraensusanna cneupronovelbiomarkersforneurodegenerativediseases AT teunissencharlotte cneupronovelbiomarkersforneurodegenerativediseases AT vecseilaszlo cneupronovelbiomarkersforneurodegenerativediseases AT zetterberghenrik cneupronovelbiomarkersforneurodegenerativediseases AT wiltfangjens cneupronovelbiomarkersforneurodegenerativediseases |